Brief: Oncoarendi Therapeutics Adopts Strategy For 2021-2025

Molecure SA

24/03/2021 17:15

March 24 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * ADOPTS STRATEGY FOR  2021-2025
    * IN 2021-2022 SEES EXPENSES AT ABOUT 100 MILLION ZLOTYS
    * PLANS TO CONCLUDE AT LEAST ONE PARTNERING DEAL COMPARABLE
TO THE
ONE WITH GALAPAGOS NV
    * PLANS TO SIGN PARTNERING DEAL WITH SMR PLATFORM BY END OF
2023
    * IN THE NEAREST TWO-YEAR PERIOD DOES NOT FORESEE SPO

Source text for Eikon:  ID:nEM3SbbHWa 
Further company coverage:  OAT.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))